Literature DB >> 8026916

Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.

P Trelewicz1, W Grzeszczak, R Drabczyk.   

Abstract

Endogenous opioid peptides play an important role in the pathogenesis of uraemic syndrome. The effect of insulin-induced hypoglycaemia on serum beta-endorphin (BE) concentration was studied in 27 uraemic patients and in 14 healthy subjects. Despite elevated basal BE level, that correlated positively with serum creatinine, uraemic patients showed a normal BE secretory pattern. No differences were found between uraemic patients on conservative and those on haemodialysis treatment. The influence of haemodialysis treatment on BE secretion requires further investigations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026916     DOI: 10.1007/bf02768251

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  Plasma beta endorphin in cirrhosis and renal failure.

Authors:  J R Thornton; M S Losowsky
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

2.  Serum endorphin levels in uremic patients under maintenance hemodialysis.

Authors:  J C Hwang; K T Hsu; H C Tsai; K K Lam; P W Wang
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1989-04

Review 3.  Hormonal changes in hemodialysis.

Authors:  V Bonomini; G Orsoni; M A Sorrentino; P Todeschini
Journal:  Blood Purif       Date:  1990       Impact factor: 2.614

Review 4.  Insulin resistance of uremia.

Authors:  S R Hager
Journal:  Am J Kidney Dis       Date:  1989-10       Impact factor: 8.860

5.  Effects of naloxone administration on endocrine abnormalities in chronic renal failure.

Authors:  W Grzeszczak; F Kokot; J Duława
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

6.  Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone.

Authors:  B Allolio; H M Schulte; U Deuss; D Kallabis; E Hamel; W Winkelman
Journal:  Acta Endocrinol (Copenh)       Date:  1987-04

7.  Abnormalities in the hypothalamic-pituitary-adrenocortical axis in patients with chronic renal failure.

Authors:  A Luger; I Lang; J Kovarik; H K Stummvoll; H Templ
Journal:  Am J Kidney Dis       Date:  1987-01       Impact factor: 8.860

8.  Anterior pituitary dysfunction in patients with chronic renal failure treated by hemodialysis or continuous ambulatory peritoneal dialysis.

Authors:  R S Rodger; J H Dewar; S J Turner; M J Watson; M K Ward
Journal:  Nephron       Date:  1986       Impact factor: 2.847

9.  Plasma immunoreactive beta-endorphin is elevated in uraemia.

Authors:  N Aronin; D T Krieger
Journal:  Clin Endocrinol (Oxf)       Date:  1983-05       Impact factor: 3.478

10.  Plasma beta-endorphin and beta-lipotropin in patients with end-stage renal disease--effects of hemodialysis.

Authors:  A N Elias; N D Vaziri; M Maksy
Journal:  Nephron       Date:  1986       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.